The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application for the mark LYLEQ AX. The application, identified by serial number 99492404, was filed on November 12, 2025, and pertains to oral contraceptives.

This filing signifies the applicant's intention to use the mark in the future for goods in Class 005. While this is an administrative filing and does not impose immediate compliance obligations, it is a step in the trademark registration process. Companies operating in the pharmaceutical sector should be aware of new trademark filings that may impact their own branding and product strategies.